Identification of Hepatic-like EPO as a Cause of Polycythemia

Abstract

We found that secondary erythrocytosis can be related to variants in <i>EPO</i> that lead to the production of hepatic-like EPO with an atypical glycosylation pattern and increased activity. (Funded by Région des Pays de la Loire and others; ClinicalTrials.gov number, NCT03957863.).